No Data
12 Health Care Stocks Moving In Thursday's Intraday Session
Revenues Working Against FibroGen, Inc.'s (NASDAQ:FGEN) Share Price Following 44% Dive
Express News | FibroGen Inc Files for Mixed Shelf of up to $300 Mln - SEC Filing
Goldman Sachs Maintains FibroGen(FGEN.US) With Sell Rating
Favourable Signals For FibroGen: Numerous Insiders Acquired Stock
FibroGen to Host Part II of Virtual KOL Investor Event Series to Review FG-3246 Development Program in Metastatic Castration-Resistant Prostate Cancer on June 26, 2024